Brick & Kyle Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Brick & Kyle Associates's LLY Position: Q1 2026 in Review
Brick & Kyle Associates reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $498K and leaving 3,972 shares worth $3.65M. The position accounts for 1.21% of the portfolio, ranked #30.
Brick & Kyle Associates first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Brick & Kyle Associates held 3,972 shares of Eli Lilly worth $3.65M as of Q1 2026.
- Brick & Kyle Associates sold 491 Eli Lilly shares in Q1 2026, an estimated $498K.
- Eli Lilly made up 1.21% of Brick & Kyle Associates's portfolio in Q1 2026, its #30 holding.
- Brick & Kyle Associates first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
- Brick & Kyle Associates's Eli Lilly position peaked at $4.8M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Brick & Kyle Associates's 13F filing for Q1 2026, filed 2 Jul 2026.